Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Raw Materials (2023 - 2024)

Harmony Biosciences Holdings' Raw Materials history spans 2 years, with the latest figure at $944000.0 for Q4 2024.

  • For Q4 2024, Raw Materials fell 10.94% year-over-year to $944000.0; the TTM value through Dec 2024 reached $944000.0, down 10.94%, while the annual FY2024 figure was $944000.0, 10.94% down from the prior year.
  • Raw Materials for Q4 2024 was $944000.0 at Harmony Biosciences Holdings, down from $1.0 million in the prior quarter.
  • Across five years, Raw Materials topped out at $1.1 million in Q2 2024 and bottomed at $944000.0 in Q4 2024.